Healthcare Sales & Marketing Network News: Atlas

Searching News Database: Atlas

HSMN NewsFeed - 31 Jul 2026
Ratio Therapeutics Closes $70 Million Series C Financing to Advance Clinical Development of Targeted Radiotherapeutics Pipeline and Expand Manufacturing Infrastructure
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 12 Mar 2026
Ratio Therapeutics Appoints Global Medical Leader Colin Hayward as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Mar 2024
Sionna Therapeutics Announces $182 Million Series C Financing to Advance Clinical Development of Novel Small Molecules in Cystic Fibrosis
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 13 Dec 2023
Triveni Bio Welcomes Jeff Albers and Allison Luo to its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Oct 2023
Rarebase Names Chris Moxham as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Sep 2023
MiRus(R) Announces Launch of Molybdenum-Rhenium Low Profile ATLAS(TM) MoRe(R) Foot and Ankle Plating System
Devices Orthopaedic Product Launch

HSMN NewsFeed - 28 Jun 2023
K36 Therapeutics Announces $70 Million Series B Financing to Fund Clinical Proof of Concept of KTX-1001, First-in-class Inhibitor of MMSET for Treatment of Multiple Myeloma Patients with Genetic Translocation (4;14)
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 1 Mar 2023
Chroma Medicine Secures $135M in Series B Financing to Advance Breakthrough Epigenetic Editing Technology and Expand Pipeline of Durable Precision Genomic Medicines
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 10 Nov 2022
Lipidio Pharmaceuticals Announces Close of Series A Extension Financing, Bringing Total Round to Over $20M
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 17 May 2022
Remix Therapeutics Closes $70 Million Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 26 Apr 2022
Halozyme Commences Tender Offer for All Outstanding Shares of Common Stock of Antares Pharma
Biopharmaceuticals Drug Delivery Mergers & Acquisitions

HSMN NewsFeed - 10 Feb 2022
Arkuda Therapeutics Raises $64 Million Series B Financing to Advance Pipeline of Programs Targeting Lysosomal Biology to Treat Neurodegenerative Diseases
Biopharmaceuticals Neurology Venture Capital

HSMN NewsFeed - 1 Dec 2021
Curie Therapeutics Raises $75 Million Financing to Further its Mission of Transforming Cancer Care with Precision Radiopharmaceuticals
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 29 Nov 2021
HotSpot Therapeutics Closes $100M Series C to Advance First-in-Class Allosteric Drug Discovery Platform to the Clinic
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 9 Sep 2021
Obsidian Therapeutics Announces Closing of $115 Million Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 2 Sep 2021
Disc Medicine Announces $90 Million Series B Financing to Advance Portfolio of Clinical-Stage Therapies for Hematologic Diseases
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 31 Aug 2021
Smith & Nephew launches new total ankle and total shoulder replacement technologies; showcases recently acquired Extremity Orthopaedics portfolio at AAOS
Devices Orthopaedic Product Launch

HSMN NewsFeed - 17 Aug 2021
Remix Therapeutics Names Peter Smith, PhD, as President and Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 May 2021
Vedere Bio II Launches with $77 Million Series A Financing to Develop Next Generation Ocular Gene Therapies
Biopharmaceuticals Ophthalmology Venture Capital

HSMN NewsFeed - 6 May 2021
Lilly collaborates internationally with leading diabetes technology companies to integrate connected insulin pen solutions for people with diabetes
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 6 May 2021
BD Announces Intent to Spin Off Diabetes Care Business to Enhance Focus on Innovation and Priority Growth Markets
Devices Endocrinology Acquisitions

HSMN NewsFeed - 20 Apr 2021
Zimmer Biomet Receives FDA Clearance for ROSA(R) Partial Knee System for Robotically-Assisted Partial Knee Arthroplasty
Devices Orthopaedic FDA

HSMN NewsFeed - 25 Feb 2021
Welldoc and Lilly collaborate to integrate BlueStar(R) app capabilities into Lilly's connected insulin solutions
Biopharmaceuticals Endocrinology Licensing

HSMN NewsFeed - 8 Dec 2020
Remix Therapeutics Launches with $81 Million Financing to Develop Small Molecule Therapies Designed to Reprogram RNA Processing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 19 Nov 2020
Lilly and Ypsomed collaborate to advance an automated insulin delivery system for people with diabetes
Devices Drug Delivery Endocrinology

HSMN NewsFeed - 29 Oct 2020
Q32 Bio Closes $60 Million Series B Financing, Advances to Clinical Stage Research in Therapeutics Designed to Restore Immune Homeostasis
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 15 Oct 2020
Lilly Announces Agreement to Acquire Disarm Therapeutics
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 3 Aug 2020
Stryker's Neuroform Atlas(R) Stent System granted an expanded indication, providing a new option for patients with aneurysms in the back of the brain
Devices Interventional Neurology FDA

HSMN NewsFeed - 21 May 2020
HotSpot Therapeutics Completes $65 Million Series B Financing to Advance Pipeline of Novel Allosteric Medicines
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 24 Mar 2020
Updates from Lilly about Insulin Supply and Affordability
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 28 Jan 2020
Lilly plans donation of 200,000 insulin KwikPens over next three years to support lower-income communities
Biopharmaceuticals Drug Delivery Endocrinology

HSMN NewsFeed - 27 Jan 2020
Quench Bio Closes $50M Series A Financing to Advance First-in-Class Medicines Targeting Gasdermin to Treat Severe Inflammatory Diseases
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 16 Dec 2019
Lilly to Integrate Dexcom CGM into Personalized Diabetes Management System
Devices Drug Delivery Monitoring Endocrinology

HSMN NewsFeed - 2 Dec 2019
IFM Therapeutics Announces $55.5 Million Financing to Launch and Fund New Subsidiaries and Appointment of Dr. H. Martin Seidel as Chief Executive Officer
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 20 Nov 2019
Kymera Therapeutics Promotes Nello Mainolfi, PhD, to Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Nov 2019
Arkuda Therapeutics Closes $44M Series A Financing to Advance Novel Medicines Targeting Progranulin and Lysosomal Biology to Treat Neurodegenerative Diseases
Biopharmaceuticals Neurology Venture Capital

HSMN NewsFeed - 29 Oct 2019
Disc Medicine Completes $50 Million Series A Financing led by Novo Holdings A/S to Advance New Therapies Addressing Ineffective Red Blood Cell Production
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 20 Sep 2019
CHMP Issues Positive Opinion to Expand Trulicity(R) (dulaglutide) Label to Include Results from REWIND Cardiovascular Outcomes Trial
Biopharmaceuticals Endocrinology Cardiology Regulatory

HSMN NewsFeed - 25 Jul 2019
Obsidian Therapeutics Announces Strengthening of Executive Leadership Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Jul 2019
Kymera Therapeutics Announces Leadership Transitions
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Apr 2019
Novartis to Acquire IFM Tre to Develop First-In-Class NLRP3 Antagonist Portfolio Targeting Innate Immune System
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 27 Mar 2019
Novartis receives FDA approval for Mayzent(R) (siponimod), the first oral drug to treat secondary progressive MS with active disease
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 28 Jan 2019
Indalo Therapeutics Appoints Seasoned Biopharmaceutical Executive Robert Jacks President & CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Jan 2019
Zimmer Biomet Receives FDA Clearance for ROSA(R) Knee System for Robotically-Assisted Surgeries
Devices Orthopaedic FDA

HSMN NewsFeed - 6 Dec 2018
Akero Therapeutics Appoints Mark Iwicki to its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Nov 2018
Kymera Therapeutics Announces $65 Million Series B Financing to Advance Pipeline of Targeted Protein Degraders in Oncology and Immunology
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 24 Oct 2018
FDA Approves New SynchroMed(TM) II myPTM(TM) Personal Therapy Manager That Enables Patients to Alleviate Unpredictable Pain
Devices Drug Delivery Neurology FDA

HSMN NewsFeed - 17 Oct 2018
Akero Therapeutics Expands Leadership Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Oct 2018
Results from Two Phase 3 Studies Show Lilly's Ultra Rapid Lispro (URLi) Met Primary Efficacy Endpoint in People with Type 1 and Type 2 Diabetes
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 11 Sep 2018
Andrew Cheng, MD, PhD Joins Akero Therapeutics as President and Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Jul 2018
HotSpot Therapeutics Completes $45 Million Series A Financing to Advance New Approach to Allosteric Drug Discovery
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 25 Jun 2018
Akero Therapeutics Closes $65 Million Series A Financing to Advance New Treatments for Serious Metabolic Diseases
Biopharmaceuticals Licensing Venture Capital

HSMN NewsFeed - 14 Jun 2018
New England Biolabs(R) Launches New NEBNext(R) Single Cell/Low Input RNA Library Prep Kit for Increased Transcript Detection with Ultra-low Input Amounts
Diagnostics Product Launch

HSMN NewsFeed - 25 Apr 2018
Lilly and China's NCCD announce collaboration to advance scientific understanding and care for people living with diabetes and cardiovascular disease
Biopharmaceuticals Cardiology Endocrinology

HSMN NewsFeed - 6 Apr 2018
Impax Launches a Generic Version of Estrace(R) Cream (estradiol vaginal cream, USP, 0.01%)
Biopharmaceuticals Generics Product Launch

HSMN NewsFeed - 27 Mar 2018
FDA Approves New Innovations on Hologic's 3Dimensions(TM) Mammography System, the Fastest, Highest Resolution Breast Tomosynthesis System Ever(1)
Devices Oncology Radiology FDA

HSMN NewsFeed - 26 Feb 2018
New Data Show Lilly's Trulicity(R) (dulaglutide) in Combination with an SGLT-2 Inhibitor Improves Blood Sugar Control in People with Type 2 Diabetes
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 23 Jan 2018
Disarm Therapeutics Appoints Thomas Engber as Senior Vice President, Head of Neuropharmacology and Translational Sciences
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 11 Jan 2018
New Study Shows Superiority of Intrathecal Baclofen Therapy (ITB Therapy(SM)) Over Oral Medication for the Treatment of Severe Post-Stroke Spasticity
Devices Drug Delivery Neurology

HSMN NewsFeed - 19 Dec 2017
Disarm Therapeutics Appoints Peter Keller Chief Business Officer
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 18 Dec 2017
Robert Stewart to Join Amneal Pharmaceuticals as President
Biopharmaceuticals Personnel Mergers & Acquisitions

HSMN NewsFeed - 24 Nov 2017
Hologic Receives FDA 510(k) Clearance of Quantra(TM) 2.2 Breast Density Assessment Software
Devices Radiology Oncology FDA

HSMN NewsFeed - 9 Nov 2017
Stryker Receives US FDA HDE Approval ror the Neuroform Atlas(TM) Stent System to Treat Wide Neck Aneurysms
Devices Interventional FDA

HSMN NewsFeed - 30 Oct 2017
Kymera Therapeutics Announces Series A to Advance Novel Therapeutic Modality and Develop Innovative Therapies
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 17 Oct 2017
Amneal And Impax To Combine
Biopharmaceuticals Generics Mergers & Acquisitions

HSMN NewsFeed - 8 Sep 2017
Replimune Raises $55 Million to Advance its Oncolytic Immunotherapy Programs
Biopharmaceuticals Oncology Venture Capital Personnel

HSMN NewsFeed - 23 May 2017
IFM Therapeutics Appoints H. Martin Seidel as Executive Vice President of Research and Development
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 16 Mar 2017
Moximed Closes Oversubscribed $50MM Financing Round
Devices Orthopaedic Venture Capital Personnel

HSMN NewsFeed - 9 Mar 2017
LABORIE Acquires Andromeda
Devices Urology Mergers & Acquisitions

HSMN NewsFeed - 8 Mar 2017
Spero Therapeutics Secures $51.7 Million in Oversubscribed Series C Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 14 Feb 2017
miRagen Therapeutics Completes Merger with Signal Genetics and Concurrent $40.7 Million Equity Financing
Biopharmaceuticals Mergers & Acquisitions Venture Capital

HSMN NewsFeed - 26 Jan 2017
Celgene to Acquire Delinia, Inc.
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 6 Jan 2017
GRAIL Plans to Raise in Excess of $1B in Series B Funding
Diagnostics Oncology Venture Capital

HSMN NewsFeed - 29 Nov 2016
Moximed: First Patient Treated in US Study of Atlas(R) System for Unicompartmental Knee Osteoarthritis
Devices Orthopaedic

HSMN NewsFeed - 3 Nov 2016
Eisai Welcomes Positive NICE recommendation for Halaven(R) (eribulin) for Patients with Locally Advanced or Metastatic Breast Cancer
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 1 Nov 2016
miRagen Therapeutics and Signal Genetics Sign Merger Agreement
Diagnostics Oncology Mergers & Acquisitions

HSMN NewsFeed - 7 Oct 2016
JenaValve Technology Appoints Veteran Medical Device Executive Greg Mirigian As Vice President of Research and Development
Devices Interventional Cardiology Personnel

HSMN NewsFeed - 5 Sep 2016
Eisai Bewildered as German Institute for Quality and Efficiency in Health Care (IQWIG) Fails to Recognise Additional Benefit of Halaven(R) (eribulin) in the Treatment of Advanced Liposarcoma
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 28 Jun 2016
FDA Grants Priority Review for Genentech’s OCREVUS(TM) (ocrelizumab) Biologics License Application
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 22 Jun 2016
IFM Therapeutics Raises $27 Million Series A Financing Led by Atlas Venture and Abingworth
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 9 May 2016
Theravance Biopharma Announces FDA Approval of Expanded Label for VIBATIV(R) (telavancin)
Biopharmaceuticals FDA

HSMN NewsFeed - 17 Mar 2016
Biota Pharmaceuticals Announces Sale of Antibiotic Assets to Spero Therapeutics
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 17 Feb 2016
FDA Grants Breakthrough Therapy Designation for Genentech’s Investigational Medicine Ocrelizumab in Primary Progressive Multiple Sclerosis
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 16 Feb 2016
Abbott Receives Approval in Australia for FreeStyle(R) Libre--the Revolutionary Glucose Monitoring System for People with Diabetes
Devices Endocrinology Monitoring Regulatory

HSMN NewsFeed - 8 Feb 2016
Atlas Genetics Gains CE Approval for First Product
Diagnostics Regulatory

HSMN NewsFeed - 2 Feb 2016
Spero Therapeutics Announces $30 Million Series B Preferred Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 4 Jan 2016
Padlock Therapeutics Creates West Coast Operations Appointing Scientific Co-founder Kerri Mowen, Ph.D., as Director of Biology Based in San Diego
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Dec 2015
Navitor Pharmaceuticals Announces $33 Million Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 18 Nov 2015
Moximed Announces CE Mark and First Commercial Use of Atlas(TM) Knee System
Devices Orthopaedic Regulatory Product Launch

HSMN NewsFeed - 16 Nov 2015
First US Commercial Appointment: Atlas Genetics Appoints Keith Stauffer as VP Sales & Marketing
Diagnostics Personnel

HSMN NewsFeed - 10 Nov 2015
miRagen Therapeutics Secures $41 million Series C Financing to Advance Two MicroRNA Programs into Clinical Trials
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 7 Oct 2015
Quartet Medicine Completes $23.25 Million Series A Financing
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 28 Sep 2015
Welch Allyn Introduces Braun ThermoScan(R) PRO 6000 Ear Thermometer that Offers Best-in-Class Thermometry Technology
Devices Product Launch

HSMN NewsFeed - 24 Sep 2015
Replimune Ltd Raises $30 Million Series A Financing
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 1 Sep 2015
Intellia Therapeutics Secures $70 Million in Series B Financing
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 7 Aug 2015
JenaValve Receives $26.5 Million Financing
Devices Interventional Cardiology Venture Capital

HSMN NewsFeed - 23 Jul 2015
RaNA Therapeutics Secures $55 Million in Oversubscribed Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 8 Jun 2015
Spero Completes $30 Million Financing
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 21 May 2015
Jose-Carlos Gutiérrez-Ramos, Ph.D. Joins Synlogic as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Mar 2015
Nimbus Therapeutics Raises $43 Million in Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 5 Feb 2015
Roka Bioscience Strengthens Management Team to Drive Growth
Diagnostics Personnel

HSMN NewsFeed - 18 Nov 2014
Intellia Therapeutics Announces $15 Million in Funding to Develop Therapeutic Products Utilizing CRISPR-Cas9 Gene Editing Technology
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 23 Oct 2014
Quartet Medicine Launches with $17 Million Series A Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 22 Jul 2014
Synlogic Secures $29.4 Million Series A Financing Led by Atlas Venture and New Enterprise Associates
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 7 Jul 2014
JenaValve Names David J. Drachman Chief Executive Officer
Devices Cardiology Personnel

HSMN NewsFeed - 19 Jun 2014
Navitor Pharmaceuticals Launches with $23.5 Million Series A Financing for Novel Drug Discovery Targeting Cellular Nutrient Signaling to Treat Chronic Diseases and Rare Disorders
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 20 May 2014
Spero Therapeutics Appoints Thomas Parr, Ph.D. as Chief Scientific Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 May 2014
Lysosomal Therapeutics Inc. Receives $4.8 Million in Seed Funding
Biopharmaceuticals Neurology Venture Capital

HSMN NewsFeed - 8 Apr 2014
JenaValve Expands Series C Venture Financing Round
Devices Interventional Cardiology Venture Capital

HSMN NewsFeed - 17 Feb 2014
CoStim Pharmaceuticals, Inc. Acquired by Novartis
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 31 Jan 2014
Eli Lilly and Company Provides Statement in Response to Sanofi U.S. Lawsuit
Biopharmaceuticals Endocrinology Litigation

HSMN NewsFeed - 13 Jan 2014
Lilly Announces Acquisition of CGRP Antibody for Migraine Prevention from Arteaus Therapeutics
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 27 Nov 2013
Atlas Appoints David Whitaker as Operations Director
Diagnostics Personnel

HSMN NewsFeed - 3 Oct 2013
Atlas Spine Launches Apelo MIS Pedicle Screw System
Devices Orthopaedic Neurosurgery Product Launch

HSMN NewsFeed - 5 Sep 2013
ThromboGenics Acquires Exclusive Rights from Bicycle Therapeutics to Develop and Commercialize Novel Drugs Inhibiting a Target for Diabetic Macular Edema
Biopharmaceuticals Ophthalmology Licensing

HSMN NewsFeed - 23 Jul 2013
JenaValve Raises $62.5 Million In Venture Funding
Devices Interventional Cardiology Venture Capital

HSMN NewsFeed - 23 Jul 2013
RaySearch Laboratories: RayStation(R) 4.0 Released
Devices Oncology Product Launch

HSMN NewsFeed - 9 May 2013
Abbott Announces CE Mark for Test to Aid Doctors with Diagnosing and Monitoring Diabetes
Diagnostics Endocrinology Regulatory

HSMN NewsFeed - 20 Mar 2013
Zimmer Launches a New Era in Knee Replacement with Persona(TM) The Personalized Knee System
Devices Orthopaedic Product Launch

HSMN NewsFeed - 4 Feb 2013
JenaValve Appoints John F. Migliazza, Chief Operating Officer
Devices Interventional Cardiology Personnel

HSMN NewsFeed - 4 Dec 2012
Zafgen Secures $21 Million in Series D Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 28 Oct 2012
Varian Medical Systems Unveils EDGE(TM) Radiosurgery Suite -- A Comprehensive Solution for Non-Invasive Surgical Procedures
Devices Oncology

HSMN NewsFeed - 10 Oct 2012
Genocea Closes $30 Million in Series C Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 8 Oct 2012
Elekta and Brainlab Collaborate to Enhance Radiosurgery Planning Power
Devices Neurosurgery Oncology

HSMN NewsFeed - 18 May 2012
ApniCure Receives FDA 510(k) Clearance to Market Winx(TM) Sleep Therapy System for Treatment of Obstructive Sleep Apnea
Devices FDA

HSMN NewsFeed - 9 May 2012
Janssen Research & Development Submits Supplemental New Drug Application to U.S. FDA for XARELTO(R) (rivaroxaban) to Reduce the Risk of Stent Thrombosis in Patients with Acute Coronary Syndrome
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 8 May 2012
Varian Medical Systems Spotlights Advanced Disease Specific Options at ESTRO 2012 in Barcelona
Devices Oncology

HSMN NewsFeed - 24 Apr 2012
miRagen Therapeutics Secures $20 Million Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 14 Feb 2012
Biogen Idec to Acquire Stromedix
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 26 Jan 2012
Celgene to Acquire Avila Therapeutics
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 28 Nov 2011
Toshiba Introduces the New Vantage Titan 1.5T MR Series
Devices Radiology

HSMN NewsFeed - 8 Nov 2011
Abbott Reports Five-Year Data for HUMIRA(R) (Adalimumab) in Ankylosing Spondylitis
Biopharmaceuticals

HSMN NewsFeed - 2 Nov 2011
Abbott to Present Broad Spectrum of Compelling Data for HUMIRA(R) (Adalimumab) at American College of Rheumatology Annual Scientific Meeting
Biopharmaceuticals

HSMN NewsFeed - 1 Nov 2011
Boston Scientific Announces Schedule of Events at TCT Scientific Symposium
Devices Interventional Cardiology

HSMN NewsFeed - 27 Oct 2011
Toshiba Introduces the Industry’s Only 16-Channel MR Flex Coils
Devices Radiology

HSMN NewsFeed - 30 Sep 2011
JenaValve Technology is First in Receiving CE Certification for a True Second-Generation Transapical TAVI System
Devices Cardiology Regulatory

HSMN NewsFeed - 8 Aug 2011
Toshiba’s Patient Friendly 3T MR System Receives FDA Clearance
Devices Radiology FDA

HSMN NewsFeed - 12 Jul 2011
MacPherson Medical Announces FDA 510(k) Clearance of Stat-Mat(R) Minor
Devices Surgery

HSMN NewsFeed - 7 Jul 2011
Zafgen Secures $33 Million Series C Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 28 Jun 2011
Nimbus Discovery Secures $24 Million Series A Financing
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 21 Jun 2011
Bydureon Receives Marketing Authorization in Europe
Biopharmaceuticals Endocrinology Regulatory

HSMN NewsFeed - 2 Jun 2011
Animas(R) Vibe, the First Integrated Offering from Animas Corporation and Dexcom, Inc., Receives European CE Mark Approval
Devices Monitoring Drug Delivery Regulatory

HSMN NewsFeed - 25 Apr 2011
Boston Scientific Announces FDA Approval and U.S. Launch of ION Platinum Chromium Stent System
Devices Interventional Cardiology FDA

HSMN NewsFeed - 15 Apr 2011
BYDUREON Recommended for Approval in Europe
Biopharmaceuticals Endocrinology Regulatory

HSMN NewsFeed - 24 Feb 2011
Toshiba’s reNEW Upgrade Program Provides Pathway for Accessing the Latest in MR Technology
Devices Radiology

HSMN NewsFeed - 11 Jan 2011
Lilly and Boehringer Ingelheim Announce Strategic Alliance to Bring New Diabetes Treatments to Patients Worldwide
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 2 Dec 2010
New Toshiba Vantage Titan HSR 1.5T Produces Outstanding Image Quality for Advanced MR Applications
Devices Radiology

HSMN NewsFeed - 1 Dec 2010
Toshiba’s 3T MR Enhances Patient Comfort and Improves Exam Efficiency
Devices Radiology

HSMN NewsFeed - 23 Nov 2010
Toshiba Announces New M-Power User Interface
Devices Radiology

HSMN NewsFeed - 9 Nov 2010
Toshiba Introduces 32 Element Coils for Its Vantage Titan MR Systems
Devices Radiology

HSMN NewsFeed - 1 Oct 2010
Elekta Launches ABAS 2.0 Autosegmentation Software Used to Plan Radiation Therapy in Patients With Cancer
Devices Oncology

HSMN NewsFeed - 22 Sep 2010
Long-Term Data Show Advantages for TAXUS(R) Liberte(R) Stent in Small Vessels and Long Lesions
Devices Interventional Cardiology

HSMN NewsFeed - 30 Aug 2010
Toshiba Installs 1,000th MR System Worldwide
Devices Radiology

HSMN NewsFeed - 15 Jul 2010
Elekta to Highlight Intelligent Cancer Management Solutions at 2010 AAPM Annual Meeting
Devices Oncology

HSMN NewsFeed - 23 Jun 2010
Toshiba Announces Aegis Breast MR Imaging Workstation
Devices Radiology

HSMN NewsFeed - 15 Jun 2010
Toshiba MR System Improves Diagnostic Capabilities and Patient Compliance at Central Washington Hospital
Devices Radiology

HSMN NewsFeed - 14 Jun 2010
aTyr Pharma Appoints Catharine E. Johnson As Senior Vice President of Business Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 May 2010
SpineGuard Elects Founder of Danek Medical, Alan Olsen, as its Chairman
Devices Orthopaedic Neurosurgery Personnel

HSMN NewsFeed - 23 Mar 2010
First European Patients Enrolled in Largest Ever Randomised Controlled Trial of ITB Therapy(R) in Post-Stroke Patients With Severe Spasticity
Devices Neurology

HSMN NewsFeed - 22 Mar 2010
Toshiba MR Technology Shortens Brain Imaging Time
Devices Radiology

HSMN NewsFeed - 15 Mar 2010
Amylin, Lilly and Alkermes Receive Complete Response Letter From FDA for Exenatide Once Weekly Submission
Biopharmaceuticals

HSMN NewsFeed - 1 Feb 2010
Haemonetics Announces Definitive Agreement to Acquire Global Med Technologies, Inc.
Devices Mergers & Acquisitions

HSMN NewsFeed - 4 Jan 2010
Boston Scientific Announces Enrollment of First Patient in Post-Approval Study for TAXUS Liberte Stent
Devices Biopharmaceuticals Interventional Cardiology

HSMN NewsFeed - 24 Nov 2009
SpineGuard elects founder of Danek Medical, Alan Olsen, as a director
Devices Radiology Orthopaedic Neurosurgery Personnel

HSMN NewsFeed - 28 Oct 2009
Osteotech's MagniFuse(TM) Technology Used in First U.S. Surgery
Devices Orthopaedic Neurosurgery

HSMN NewsFeed - 19 Oct 2009
Velocity Medical Solutions(R) Announces New Subscription Service to Provide Adaptive Radiation Therapy (ART) Software Tools to Hospitals and Radiation Oncology Centers With Minimal Up-Front Capital Investment
Devices Oncology

HSMN NewsFeed - 1 Oct 2009
Astellas and Theravance Announce Approval of VIBATIV(TM) (telavancin) in Canada for the Treatment of Complicated Skin and Skin Structure Infections
Biopharmaceuticals Regulatory

HSMN NewsFeed - 29 Sep 2009
Boehringer Ingelheim's Diabetes Pipeline Continues to Advance as the Company Announces Conclusion of Robust Phase III Clinical Program for linagliptin
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 22 Sep 2009
TAXUS(R) Liberte(R) Stent Continues to Demonstrate Significant Improvements Over TAXUS(R) Express(R) Stent in Small Vessels and Long Lesions
Devices Interventional Cardiology

HSMN NewsFeed - 24 Aug 2009
FDA Approves XYZAL(R) For Use In Children Age Six Months And Older For The Relief Of Perennial Allergic Rhinitis And Chronic Idiopathic Urticaria
Biopharmaceuticals FDA

HSMN NewsFeed - 27 Jul 2009
Avila Therapeutics, Inc. Closes $30 Million Series B Financing
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 16 Jul 2009
FDA Approves Boston Scientific's TAXUS(R) Liberte(R) Long Stent
Devices Interventional Cardiology FDA

HSMN NewsFeed - 12 Jun 2009
Abbott Announces Launch of Next-Generation Embolic Protection System
Devices Interventional

HSMN NewsFeed - 2 Jun 2009
miRagen Therapeutics, Inc. Accomplishes Funding Milestones and Secures Series A Extension
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 27 May 2009
FDA Approves Boston Scientific's Next-Generation TAXUS(R) Liberte(R) Atom(TM) Stent System
Devices Interventional Cardiology

HSMN NewsFeed - 15 May 2009
Boston Scientific Announces Schedule for EuroPCR 2009
Devices Interventional Cardiology

HSMN NewsFeed - 15 May 2009
Avila Therapeutics Appoints Katrine S. Bosley as Company's First CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 May 2009
Journal of American College of Cardiology Article Reports Fewer Repeat Procedures With Boston Scientific's TAXUS(R) Liberte(R) Stent
Devices Interventional Cardiology

HSMN NewsFeed - 6 May 2009
Archemix Appoints Ken Bate as President and Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 29 Apr 2009
Amylin and Lilly Announce Plans to Develop Pen Device for Exenatide Once Weekly
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 24 Apr 2009
St. Jude Medical Announces CE Mark Approval of Remote Care System for Implantable Cardiac Devices
Devices Cardiology Regulatory

HSMN NewsFeed - 26 Mar 2009
Exenatide Clinical Data Analysis Shows No Increased Risk of Cardiovascular Events
Biopharmaceuticals Endocrinology Cardiology

HSMN NewsFeed - 11 Mar 2009
Shire Announces Launch of FOSRENOL(R) in Japan
Biopharmaceuticals Regulatory

HSMN NewsFeed - 10 Mar 2009
Abbott Launches VOYAGER(TM) NC Coronary Balloon Catheter
Devices Interventional Cardiology

HSMN NewsFeed - 5 Feb 2009
Boston Scientific Submits Final Modules to FDA for Approval of Second-Generation Small Vessel and Long Lesion Stents
Devices Interventional Cardiology

HSMN NewsFeed - 27 Jan 2009
Archemix Announces Continued Progress with Business Strategy
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Jan 2009
St. Jude Medical Announces Japanese Approval of Atlas II ICD
Devices Cardiology Regulatory

HSMN NewsFeed - 8 Jan 2009
Howard Feldman Joins Bristol-Myers Squibb as Vice President and Therapeutic Area Head, Global Clinical Research, Neuroscience
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Oct 2008
InfaCare Pharmaceutical Corporation Raises $28 Million in Series B Financing to Advance Its Neonatal Pipeline
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 27 Oct 2008
Salinas Valley Memorial Healthcare System Provides Full Range of Cardiac Imaging Solutions with Multiple Toshiba Modalities
Devices Radiology

HSMN NewsFeed - 12 Oct 2008
Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent
Devices Interventional Cardiology

HSMN NewsFeed - 10 Oct 2008
Boston Scientific Announces FDA Approval of Second-Generation TAXUS(R) Liberte(R) Drug-Eluting Stent
Devices Interventional Cardiology FDA

HSMN NewsFeed - 19 Sep 2008
Elekta Announces Availability of Elekta Infinity With VMAT Technology for Fast, More Precise Treatment of Cancer
Devices Oncology

HSMN NewsFeed - 16 Sep 2008
Elekta Announces Availability of Elekta Infinity With VMAT Technology for Fast, More Precise Treatment of Cancer
Devices Oncology

HSMN NewsFeed - 3 Sep 2008
Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel
Biopharmaceuticals Cardiology

HSMN NewsFeed - 22 Aug 2008
CMS, Inc., an Elekta Company, Receives FDA 510(k) Clearance for Atlas-Based Autosegmentation Software
Devices Oncology FDA

HSMN NewsFeed - 12 Aug 2008
Stromedix Receives Orphan Drug Designation for STX-100 in Chronic Allograft Nephropathy
Biopharmaceuticals FDA

HSMN NewsFeed - 15 Jul 2008
St. Jude Medical Announces FDA Approval of Wireless Transmitter to Monitor Patients' Implanted Cardiac Devices
Devices Cardiology FDA Monitoring

HSMN NewsFeed - 24 Jun 2008
Urologix Announces Appointment of CEO and Director
Devices Urology Personnel

HSMN NewsFeed - 23 Jun 2008
BioAlliance Pharma extends its Loramyc(TM) License to China with NovaMed Pharmaceuticals
Biopharmaceuticals Licensing

HSMN NewsFeed - 13 Jun 2008
Data Show that Abbott's HUMIRA(R) (adalimumab) Reduced the Signs and Symptoms of Ankylosing Spondylitis Up to Three Years
Biopharmaceuticals

HSMN NewsFeed - 22 May 2008
Atlas Spine Launches Stature(TM) Vertebral Body Replacement System
Devices Neurosurgery Orthopaedic

HSMN NewsFeed - 21 May 2008
Daiichi Sankyo Co., Ltd. Announces Acquisition of Biotech Firm U3 Pharma AG
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 19 May 2008
Miragen Therapeutics, Inc. Receives $8 M in Venture Capital Financing for Development of MicroRNA-based Therapies
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 22 Apr 2008
Resolvyx Pharmaceuticals Raises $25 Million in Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 18 Apr 2008
CMS, Inc. Applies for 510(k) for Atlas-Based Autosegmentation
Devices Oncology

HSMN NewsFeed - 3 Apr 2008
Atlas Spine Releases Back-PAK(TM) Discectomy Set
Devices Neurosurgery Orthopaedic

HSMN NewsFeed - 5 Mar 2008
FDA Accepts for Review Theravance's Complete Response to Approvable Letter for Telavancin for the Treatment of Complicated Skin and Skin Structure Infections
Biopharmaceuticals FDA

HSMN NewsFeed - 25 Feb 2008
Cypress Bioscience to Acquire Proprius Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 22 Jan 2008
St. Jude Medical Announces FDA Approval of Next Generation Internet-Based Data Management System for Implantable Cardiac Devices
Devices Cardiology FDA

HSMN NewsFeed - 22 Jan 2008
St. Jude Medical Announces FDA and European CE Mark Approval of the QuickFlex Family of Leads
Devices Cardiology FDA Regulatory

HSMN NewsFeed - 22 Jan 2008
Novexel and Forest Laboratories Announce License Agreement for NXL 104, a Novel Broad-Spectrum Beta Lactamase Inhibitor
Biopharmaceuticals Licensing

HSMN NewsFeed - 21 Dec 2007
TAXUS(R) Liberte(TM) Drug-eluting Coronary Stent System Receives CE Mark for Use in Diabetic Patients
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 6 Dec 2007
Monotherapy BYETTA(R) Showed Significant Improvement in Glucose Control and Weight Loss in Adults with Type 2 Diabetes
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 29 Nov 2007
Study Presented at RSNA Supports CADstream(R) for the Evaluation of Kinetics in Breast MRI
Devices Radiology

HSMN NewsFeed - 28 Nov 2007
Antibody Engineering Company f-star Raises EUR 3.0 Million in a Second Closing of its Series A Financing Round From Novo A/S
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 26 Nov 2007
Toshiba Introduces New Vantage Titan MR System at RSNA
Devices Radiology

HSMN NewsFeed - 19 Nov 2007
Confirma to Showcase the Access Breast Coil(R) at RSNA in Chicago
Devices Radiology

HSMN NewsFeed - 8 Nov 2007
Lodotra(TM) Shows a Sustained Reduction of Morning Stiffness in Patients with Rheumatoid Arthritis Treated with Lodotra(TM) for 12 Months
Biopharmaceuticals

HSMN NewsFeed - 4 Nov 2007
In Landmark Phase III Head-to-Head Study, Prasugrel Statistically Superior to Clopidogrel in Reducing Risk of Heart Attack
Biopharmaceuticals Interventional Cardiology

HSMN NewsFeed - 1 Nov 2007
Generex Biotechnology Receives Regulatory Approval to Sell Generex Oral-lyn in India
Biopharmaceuticals Drug Delivery Endocrinology Regulatory

HSMN NewsFeed - 22 Oct 2007
Boston Scientific's Next-Generation Stent Shows Improved Clinical Outcomes in Complex Lesions
Devices Interventional Cardiology

HSMN NewsFeed - 19 Oct 2007
Xytis Names Gordon H. Busenbark as Chief Financial Officer
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 4 Oct 2007
Nitec Pharma Expands Senior Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Sep 2007
Bristol-Myers Squibb to Acquire Adnexus Therapeutics
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 21 Sep 2007
One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 10 Sep 2007
Antibody Engineering Company f-star Raises EUR 6.0 Million in Series A Financing From Aescap Venture and Atlas Venture
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 3 Sep 2007
Nitec Pharma AG Announces Appointments of CEO & CFO in Preparation for Launch of Lodotra(R)
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Sep 2007
Safety Profile of TAXUS(R) Liberte(TM) Stent System Highlighted in World's Largest Stent Registry
Devices Interventional Cardiology

HSMN NewsFeed - 16 Jul 2007
St. Jude Medical Announces Japanese Approval of CRT-D Products to Treat Heart Failure Patients
Devices Cardiology Regulatory

HSMN NewsFeed - 11 Jul 2007
Adnexus Therapeutics Appoints Martin Freed, MD as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Jun 2007
BYETTA(R) Study Showed Comparable Blood Glucose Control to Insulin
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 23 Jun 2007
BYETTA(R) Treatment for Three and a Half Years Associated with Reductions in Cardiovascular Risk Factors in People with Type 2 Diabetes
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 19 Jun 2007
New Study Demonstrates Significant Economic and Clinical Value of NT-proBNP Testing for the Management of Heart Failure
Diagnostics Cardiology

HSMN NewsFeed - 18 Jun 2007
Confirma Appoints New Vice President of Sales
Devices Radiology Oncology Personnel

HSMN NewsFeed - 4 Jun 2007
Positive Results for Second-Generation Taxus(R) Liberte(TM) Coronary Stent System Highlighted in Journal of American College of Cardiology
Devices Interventional Cardiology

HSMN NewsFeed - 30 May 2007
Theravance Announces Acceptance of Telavancin MAA for the Treatment of Complicated Skin and Soft Tissue Infections in Europe
Biopharmaceuticals Regulatory

HSMN NewsFeed - 17 May 2007
Given Imaging Receives U.S. Marketing Clearance for PillCam(R) SB 2 and RAPID(R) 5 Software
Devices Gastroenterology FDA

HSMN NewsFeed - 7 May 2007
Toshiba Installs First Vantage Powered by Atlas MRI System at Steinberg Diagnostic Medical Imaging Center
Devices Radiology

HSMN NewsFeed - 1 May 2007
Astellas and Theravance Announce Submission of Telavancin MAA for the Treatment of Complicated Skin and Soft Tissue Infections in Europe
Biopharmaceuticals Regulatory

HSMN NewsFeed - 18 Apr 2007
St. Jude Medical Announces FDA Approval of Internet-Based Data Management System For Implantable Cardiac Devices
Devices Cardiology FDA

HSMN NewsFeed - 9 Apr 2007
Sirion Therapeutics Completes $45 Million Series B Financing
Biopharmaceuticals Ophthalmology Venture Capital

HSMN NewsFeed - 27 Mar 2007
Toshiba Showcases Vantage Atlas MRI System at American College of Cardiology Annual Meeting
Devices Cardiology Radiology

HSMN NewsFeed - 20 Mar 2007
St. Jude Medical Announces FDA Approval of First U.S. Heart Failure Device with AF Suppression Technology
Devices Cardiology FDA

HSMN NewsFeed - 13 Mar 2007
Xytis Enrolls First Patient in Phase II Clinical Study With Anatibant (XY2405) for Traumatic Brain Injury
Biopharmaceuticals Neurology

HSMN NewsFeed - 26 Feb 2007
Bristol-Myers Squibb Company and Adnexus Therapeutics Announce Collaboration to Develop and Commercialize Innovative Oncology Compounds
Biopharmaceuticals Oncology

HSMN NewsFeed - 20 Feb 2007
Theravance Announces FDA Acceptance of Telavancin NDA
Biopharmaceuticals

HSMN NewsFeed - 20 Feb 2007
New Storage Instructions Approved for BYETTA(R)
Biopharmaceuticals Endocrinology FDA

HSMN NewsFeed - 1 Feb 2007
Ivrea Pharmaceuticals Appoints Daniel S. Lynch as President and Chief Executive Officer
Biopharmaceuticals

HSMN NewsFeed - 1 Feb 2007
AstraZeneca Acquires Arrow Therapeutics To Broaden Anti-Infective Capabilities
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 9 Jan 2007
Xytis Begins Phase II Clinical Study with Anatibant (XY2405) for Traumatic Brain Injury
Biopharmaceuticals Neurosurgery

HSMN NewsFeed - 8 Jan 2007
Proprius Pharmaceuticals Secures up to $17MM in Series A Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 5 Jan 2007
Xytis Pharmaceuticals Names Dr. Vincent F. Simmon President, Chief Executive Officer and Director
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Jan 2007
FDA Approves BYETTA(R) (exenatide) Injection for Expanded Combination Use
Biopharmaceuticals Endocrinology FDA

HSMN NewsFeed - 22 Dec 2006
FDA Approves BYETTA(R) (exenatide) Injection for Expanded Combination Use
Biopharmaceuticals Endocrinology FDA

HSMN NewsFeed - 5 Dec 2006
Indevus and Sanofi-Aventis' Spin-Out Company, Novexel, Announce Out-licensing of Aminocandin Anti-fungal
Biopharmaceuticals Licensing

HSMN NewsFeed - 5 Dec 2006
New Data Shows Rimonabant Benefited Patients with Type 2 Diabetes by Improving Blood Sugar Control, Reducing Weight and Acting on Other Cardiometabolic Risk Factors
Biopharmaceuticals Endocrinology Cardiology

HSMN NewsFeed - 29 Nov 2006
Study Presented at 92nd Annual RSNA Meeting Demonstrates That CADstream(TM) May Increase Confidence in Breast MRI Interpretation
Devices Radiology Oncology

HSMN NewsFeed - 28 Nov 2006
Adnexus Therapeutics Appoints Bruce A. Silver, MD, FACP as Medical Director
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 28 Nov 2006
Toshiba Showcases Vantage Atlas Plus Large Bore System at RSNA
Devices Radiology

HSMN NewsFeed - 28 Nov 2006
Toshiba Features New 3T MR System at RSNA
Devices Radiology

HSMN NewsFeed - 27 Nov 2006
Toshiba Announces FDA Clearance for New Vantage Atlas MRI System
Devices Radiology FDA

HSMN NewsFeed - 21 Nov 2006
BYETTA(R) (exenatide) Approved for Treatment of Type 2 Diabetes by European Commission
Biopharmaceuticals Endocrinology Regulatory

HSMN NewsFeed - 16 Nov 2006
Neurotech(TM), Inc. Completes $35 Million Private Equity Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 6 Nov 2006
ARCA Discovery Names Richard B. Brewer President and Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Oct 2006
TAXUS(R) stents demonstrate excellent efficacy and safety in studies presented at TCT 2006
Biopharmaceuticals Devices Interventional Cardiology

HSMN NewsFeed - 25 Oct 2006
Safety and Efficacy Benefits of Next-Generation TAXUS(R) Liberte(TM) Stent Sustained at Twelve Months
Devices Interventional Cardiology

HSMN NewsFeed - 23 Oct 2006
New Study Shows Prasugrel Achieves Faster Onset and Higher Levels of Platelet Inhibition than Clopidogrel at Approved or Higher Doses
Biopharmaceuticals Cardiology

HSMN NewsFeed - 18 Oct 2006
Boston Scientific to Highlight Broad Range of Clinical Trial Results Reinforcing Safety and Efficacy of TAXUS(R) Coronary Stent Systems at TCT 2006
Devices Interventional Cardiology

HSMN NewsFeed - 16 Oct 2006
InfaCare Pharmaceutical Appoints Dr. Ronald Dundore, Vice President of Regulatory and Quality Affairs
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 Oct 2006
Theravance Announces Additional Results From Successful Phase 3 Telavancin Complicated Skin and Skin Structure Program
Biopharmaceuticals

HSMN NewsFeed - 4 Oct 2006
St. Jude Medical Announces European Approval of Atlas II ICD and Atlas II Heart Failure Devices
Devices Cardiology Regulatory

HSMN NewsFeed - 4 Oct 2006
SkyePharma Reports Positive Phase III and EU Filing for Lodotra(TM)
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 28 Sep 2006
St. Jude Medical Comments on Heart Rhythm Society Recommendations on Device Performance Policies and Guidelines
Devices Cardiology

HSMN NewsFeed - 21 Sep 2006
Exenatide Receives Positive Opinion From the European Committee for Medicinal Products for Human Use for the Treatment of Type 2 Diabetes
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 14 Sep 2006
Study Shows Exenatide Improves Blood Sugar Levels as Effectively as Biphasic Insulin Aspart
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 18 Jul 2006
St. Jude Medical Announces FDA Approval of Atlas II ICD and Atlas II Heart Failure Devices
Devices Cardiology FDA

HSMN NewsFeed - 5 Jul 2006
Four-Year Follow-up Study Shows Intermediate Term Efficacy of New Minimally Invasive X STOP Procedure for Common Cause of Low Back Pain
Devices Neurosurgery Orthopaedic

HSMN NewsFeed - 23 Jun 2006
New Phase III Data Demonstrate That Abbott's HUMIRA(R) (Adalimumab) Sustained Reduction in Signs and Symptoms Through One Year in Patients With Ankylosing Spondylitis
Biopharmaceuticals

HSMN NewsFeed - 21 Jun 2006
First AdNectin Therapeutic, CT-322, Clears FDA IND Review to Start Clinical Trials
Biopharmaceuticals Oncology

HSMN NewsFeed - 20 Jun 2006
Study of Boston Scientific's Carotid WALLSTENT(TM) Monorail(TM) Design Shows Superior Safety Results in Stroke Prevention
Devices Interventional

HSMN NewsFeed - 2 Jun 2006
BrainLAB Opens new Possibilities for Drug Delivery with iPlan Flow
Devices Oncology

HSMN NewsFeed - 16 May 2006
TAXUS ATLAS Trial Supports Excellent Deliverability and Proven Outcomes of TAXUS(R) Liberté(TM) stent system
Devices Interventional Cardiology

HSMN NewsFeed - 16 May 2006
TAXUS ATLAS Trial Supports Superior Deliverability and Proven Outcomes of TAXUS(R) Liberte(TM) Stent System
Devices Interventional Cardiology

HSMN NewsFeed - 10 May 2006
The Shape of Things to Come: Gender Solutions(TM) High-Flex Knee is the First Knee Replacement Shaped to Fit a Woman's Anatomy
Devices Orthopaedic FDA

HSMN NewsFeed - 9 May 2006
Boston Scientific to Release Latest Clinical Trial Results on Market-Leading TAXUS(R) Coronary Stent Systems at EuroPCR
Devices Interventional Cardiology

HSMN NewsFeed - 8 May 2006
Confirma Announces Expanded Breast MRI Capabilities for CADstream(TM)
Devices Radiology Oncology

Return to NewsFeed

Additional items found! 112

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 112 additional stories matching:
Atlas
(Password required)

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!